| | Hang Seng Index | 26.440 HKD | +0.620 | +2.401% | 195.64M | 5.13B | 26.071 (+1.416%) HKD as at 2025/12/30 | | |
| | Hang Seng China Enterprises Index | 93.580 HKD | +2.320 | +2.542% | 42.72M | 3.97B | 92.157 (+1.545%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index | 5.610 HKD | +0.220 | +4.082% | 482.18M | 2.67B | 5.464 (+2.680%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.505 HKD | +0.400 | +7.835% | 177.65M | 955.62M | 5.240 (+5.049%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.334 HKD | -0.112 | -7.746% | 450.78M | 615.26M | 1.413 (-5.604%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.754 HKD | -0.086 | -4.674% | 135.78M | 241.49M | 1.802 (-2.675%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 6.140 HKD | +0.295 | +5.047% | 31.91M | 192.99M | 5.991 (+2.490%) HKD as at 2025/12/30 | | |
| | | 10.510 HKD | +0.090 | +0.864% | 15.24M | 159.86M | 10.466 (+0.417%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index (net total return version) | 12.010 HKD | +0.470 | +4.073% | 9.88M | 116.90M | 11.699 (+2.660%) HKD as at 2025/12/30 | | |
| | Hang Seng TECH Index | 5.700 HKD | +0.215 | +3.920% | 17.86M | 100.67M | 5.555 (+2.610%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 17.150 HKD | +1.000 | +6.192% | 5.90M | 98.64M | 16.139 (+6.263%) HKD as at 2025/12/30 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 19.620 HKD | +0.060 | +0.307% | 2.15M | 42.17M | 19.669 (-0.250%) HKD as at 2025/12/30 | | |
| | | 9.350 HKD | +0.145 | +1.575% | 4.06M | 37.83M | 9.263 (+0.935%) HKD as at 2025/12/30 | | |
| | London Gold Fixing Price | 20.500 HKD | +0.080 | +0.392% | 1.41M | 28.88M | 20.595 (-0.460%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Samsung Electronics Co Ltd | 36.100 HKD | +2.600 | +7.761% | 808.10K | 28.68M | 33.185 (+8.786%) HKD as at 2025/12/30 | | |
| | London Gold Fixing Price | 3,125.000 HKD | +13.000 | +0.418% | 6.75K | 21.05M | 398.810 (+0.593%) USD as at 2025/12/29 | | |
| | London Gold Fixing Price | 18.340 CNY | +0.020 | +0.109% | 1.07M | 19.72M | 18.483 (-0.772%) CNY as at 2025/12/30 | | |
| | CSI 300 Index | 54.040 HKD | +0.720 | +1.350% | 301.15K | 16.24M | 53.699 (+0.634%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises Index | 3.518 HKD | +0.118 | +3.471% | 3.06M | 10.61M | 3.426 (+2.679%) HKD as at 2025/12/30 | | |
| | FTSE China A50 Index | 16.570 HKD | +0.200 | +1.222% | 545.17K | 9.02M | 16.490 (+0.488%) HKD as at 2025/12/30 | | |
| | Hang Seng Biotech Index | 14.550 HKD | +0.200 | +1.394% | 614.70K | 8.90M | 14.515 (+0.243%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 26.840 HKD | +0.200 | +0.751% | 320.50K | 8.55M | 26.905 (-0.242%) HKD as at 2025/12/30 | | |
| | CSI 300 Index | 34.900 HKD | +0.200 | +0.576% | 210.40K | 7.31M | 34.743 (+0.452%) HKD as at 2025/12/30 | | |
| | Hang Seng High Dividend Yield Index | 30.540 HKD | +0.140 | +0.461% | 234.31K | 7.14M | 30.441 (+0.326%) HKD as at 2025/12/30 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index | 8.270 HKD | +0.270 | +3.375% | 737.00K | 6.06M | 8.263 (+0.086%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.222 HKD | +0.002 | +0.062% | 1.80M | 5.82M | 3.201 (+0.672%) HKD as at 2025/12/30 | | |
| | NASDAQ-100 Index | 4,815.000 HKD | +5.000 | +0.104% | 1.08K | 5.18M | 620.870 (-0.441%) USD as at 2025/12/29 | | |
| | FTSE China A50 Index | 15.320 HKD | +0.200 | +1.323% | 326.41K | 4.98M | 15.286 (+0.221%) HKD as at 2025/12/30 | | |
| | | 10.920 HKD | +0.100 | +0.924% | 442.50K | 4.82M | 10.845 (+0.696%) HKD as at 2025/12/30 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average | 29.200 HKD | -0.380 | -1.285% | 162.75K | 4.80M | 29.738 (-1.809%) HKD as at 2025/12/30 | | |